您当前所在的位置:首页 > 产品中心 > 产品信息
硼烷-N,N-二乙基苯胺络合物_分子结构_CAS_13289-97-9)
点击图片或这里关闭

硼烷-N,N-二乙基苯胺络合物

产品号 179043 公司名称 Sigma Aldrich
CAS号 13289-97-9 公司网站 http://www.sigmaaldrich.com
分子式 C10H18BN 电 话 1-800-521-8956
分子量 163.06762 传 真
纯 度 电子邮件
保 存 Chembase数据库ID: 148945

产品价格信息

请登录

产品别名

标题
Borane N,N-diethylaniline complex
IUPAC标准名
N,N-diethylaniline borane
IUPAC传统名
N,N-diethylaniline borane
别名
(N,N-Diethylaniline)trihydroboron
Diethylphenylamine-borane
NSC 239123

产品登记号

MDL号 MFCD00013187
EC号 236-305-2
PubChem SID 24850794
CAS号 13289-97-9

产品性质

危险公开号 10-14
安全公开号 16-33-36/37/39-43
欧盟补充危害声明 Reacts violently with water.
联合国危险货物等级 4.3
联合国危险货物编号 3398
联合国危险货物包装类别(PG) 2
德国WGK号 3
GHS危险品标识 GHS02
GHS警示词 Danger
GHS危险声明 H225-H261
MSDS下载 下载链接
个人保护装置 Eyeshields, Faceshields, full-face respirator (US), Gloves, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter
GHS警示性声明 P210-P231 + P232-P422
RID/ADR UN 3398 4.3/PG 2
线性分子式 C6H5N(C2H5)2·BH3
密度 0.917 g/mL at 25 °C(lit.)
闪点 21 °C
闪点 69.8 °F
熔点 -30--27 °C(lit.)

产品详细信息

详细说明 (English)
Packaging
25, 100 g in Sure/Seal™
Application
Reactant for:
• Diastereoselective reduction of prochiral enone intermediates1
• Borylation of aryl halides2
• Reductions of ketones, acids, esters, amides, and nitriles3
• Investigations of borane source on enantioselectivity in enantiopure oxazaborolidine-catalyzed asymmetric borane reduction of ketones4Reactant for synthesis of:
• Chromanol derivatives as CETP inhibitors for the treatment of cardiovascular disease5
• Allylic alcohols via enantioselective reductions6
• Pinacolboranes for one-pot synthesis of unsymmetrical biaryls7
详细说明 (简体中文)
包装
25, 100 g in Sure/Seal™
Application
Reactant for:
• Diastereoselective reduction of prochiral enone intermediates1
• Borylation of aryl halides2
• Reductions of ketones, acids, esters, amides, and nitriles3
• Investigations of borane source on enantioselectivity in enantiopure oxazaborolidine-catalyzed asymmetric borane reduction of ketones4Reactant for synthesis of:
• Chromanol derivatives as CETP inhibitors for the treatment of cardiovascular disease5
• Allylic alcohols via enantioselective reductions6
• Pinacolboranes for one-pot synthesis of unsymmetrical biaryls7

参考文献